-+ 0.00%
-+ 0.00%
-+ 0.00%

BactiQuant Reissues Q3 Trading Statement to Include Missing Report Attachment

PUBT·11/10/2026 12:51:47
Listen to the news
BactiQuant Reissues Q3 Trading Statement to Include Missing Report Attachment
  • BactiQuant issued a corrected third-quarter 2026 trading statement on November 10.
  • Revenue for January-September rose 36% from 2025, primarily driven by strong growth in recurring pharmaceutical-sector revenue.
  • The company repaid its remaining kr. 7.2 million EIFO loan in the third quarter, reducing ongoing financing costs.
  • An October private placement to existing shareholders, including management and the chairman, raised net proceeds of kr. 9 million, strengthening capital.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bactiquant A/S published the original content used to generate this news brief on November 10, 2026, and is solely responsible for the information contained therein.